TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a…
BIOPROCESSING OPERATIONS: 24% REVENUE GROWTH DRIVEN BY NEWLY LAUNCHED PRODUCTS OPERATIONAL EFFICIENCIES CUT TOTAL NET LOSSES BY 29% LAUNCHED NEW STATE…
- The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα…
BASEL, Switzerland and VANCOUVER, B.C. and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid…
BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced…
WARREN, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), is a…
February 07, 2025 16:05 ET | Source: AEON Biopharma IRVINE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc.…
Topline data from Phase 3 ONWARD trials for Alumis’ ESK-001 in moderate-to-severe plaque psoriasis on track for readout in first…
January 30, 2025 05:00 ET | Source: Comanche Biopharma ILAP aims to accelerate time to market, facilitating faster patient access…
January 10, 2025 17:15 ET | Source: Matinas BioPharma Holdings, Inc. BEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) --…
